VEGFA and glioblastoma: Therefore, anti-VEGF (bevacizumab) therapy is frequently employed in “adult glioblastomas.” However, VEGF expression is relatively infrequent in “pediatric glioblastomas,” which may explain the comparative ineffectiveness of anti-VEGF therapy in children (29).